Trial document



drksid header

  DRKS00013640

Trial Description

start of 1:1-Block title

Title

Oncological Social Care Project of the BKK

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

[---]*

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Cancer diseases are potentially life-threating and associated with different medical and psycho-social stress. For this reason, the improving of coping strategies are essential for the patients. The study cohort includes patients with cancer diseases. The participants will be supported by Social Care Nurses for a period of one year. The Social Care Nurses should identify and manage deficits in the health care utilization based on structured interviews. A better patients´s knowledge of its disease can support patients in their choice of therapies with reflection of their own preferences.
The Aim of the study is to improve the quality of life and patients´ autonomy.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

The evaluation is a non-randomized, controlled, multi-center study with two modules. Module 1 analyse the improvement of subjective parameters in patient surveys. Modul 2 includes the analysis of secondary data from the statutory health care insurances. A final evaluation of structures, processes und results will investigated with a qualitative analysis of the experiences from the Social Care Nurses.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00013640
  •   2017/12/29
  •   [---]*
  •   yes
  •   Approved
  •   EA2/192/17, Ethik-Kommission der Charité -Universitätsmedizin Berlin-
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   acute leukemia, aggressive lymphoma, bronchial carcinoma, pancreatic carcinoma and colon carcinoma (advanced stage), multiple myeloma and malignant plasma cell neoplasms, metastasized malignant neoplasm of breast, metastasized malignant neoplasm of ovary, metastasized malignant neoplasm of cervix uteri, metastasized malignant neoplasm of corpus uteri, malignant neoplasm of stomach, malignant neoplasm of esophagus, metastasized malignant neoplasms of lip, oral cavity, and pharynx, metastasized malignant neoplasm of prostate, metastasized malignant neoplasm of thyroid gland, metastasized melanoma and other malignant neoplasms of skin
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Intervention Group with 150 patients: Support through 12 structured interviews and specific measures (if necessary) within 1 year
  •   Controll group with 200 patients. No Support from the Social Care Nurse
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Non-randomized controlled trial
  •   Open (masking not used)
  •   [---]*
  •   Control group receives no treatment
  •   Other
  •   Parallel
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

The primary aim of this study is to determine changes in the doctor-patient communication, the health literacy and the quality of life in the participating patients. The effects will be measured by repeated interviews within one year.

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

The secondary aim is to evaluate the association between health literacy, participation, improved communication and quality of life. In addition, objective outcomes will be measured with secondary data (statutory health insurance) to analyse the effects caused by participants in the program OSCAR (e.g. health care utilization, costs) in comparison to non-participants.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
  • Medical Center 
  • University Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2018/02/05
  •   350
  •   Multicenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

acute leukemia, aggressive lymphoma, bronchial carcinoma, pancreatic carcinoma, colon carcinoma (advanced stage), multiple myeloma and malignant plasma cell neoplasms, metastasized malignant neoplasm of breast, metastasized malignant neoplasm of ovary, metastasized malignant neoplasm of cervix uteri, metastasized malignant neoplasm of corpus uteri, malignant neoplasm of stomach, malignant neoplasm of esophagus, metastasized malignant neoplasms of lip, oral cavity, and pharynx, metastasized malignant neoplasm of prostate, metastasized malignant neoplasm of thyroid gland, metastasized melanoma and other malignant neoplasms of skin

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

advanced dementia, acute addiction

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • pronova BKK (Konsortialführung)
    • 51373   Leverkusen
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • Sächsische Krebsgesellschaft e.V.
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact other
  • start of 1:1-Block address other
    • BKK Dachverband e.V.
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • Institut für Medizinische Soziologie und RehabilitationswissenschaftCharité - Universitätsmedizin Berlin (Evaluation)
    • Ms.  PD Dr.  Liane  Schenk 
    • Charitéplatz 1
    • 10117  Berlin
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Institut für Medizinische Soziologie und Rehabilitationswissenschaft
    • Mr.  Johann  Frick 
    • Charitéplatz 1
    • 10117  Berlin
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Innovationsfonds beim Gemeinsamen Bundesausschuss
    • Wegelystr. 8
    • 10623  Berlin
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up continuing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.